AAVXF
Price
$11.05
Change
-$0.00 (-0.00%)
Updated
Jul 30 closing price
SRPT
Price
$109.11
Change
-$3.37 (-3.00%)
Updated
Nov 14 closing price
109 days until earnings call
Ad is loading...

AAVXF vs SRPT

Header iconAAVXF vs SRPT Comparison
Open Charts AAVXF vs SRPTBanner chart's image
Abivax SA
Price$11.05
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
Sarepta Therapeutics
Price$109.11
Change-$3.37 (-3.00%)
Volume$1.45M
CapitalizationN/A
AAVXF vs SRPT Comparison Chart
Loading...
SRPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AAVXF vs. SRPT commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Hold and SRPT is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (AAVXF: $11.05 vs. SRPT: $109.11)
Brand notoriety: AAVXF: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 100% vs. SRPT: 166%
Market capitalization -- AAVXF: $634.74M vs. SRPT: $10.42B
AAVXF [@Biotechnology] is valued at $634.74M. SRPT’s [@Biotechnology] market capitalization is $10.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both AAVXF and SRPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRPT’s TA Score shows that 4 TA indicator(s) are bullish.

  • SRPT’s TA Score: 4 bullish, 6 bearish.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while SRPT (@Biotechnology) price change was -9.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

SRPT is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($10.4B) has a higher market cap than AAVXF($635M). SRPT YTD gains are higher at: 13.149 vs. AAVXF (8.440).
AAVXFSRPTAAVXF / SRPT
Capitalization635M10.4B6%
EBITDAN/AN/A-
Gain YTD8.44013.14964%
P/E RatioN/A70.85-
RevenueN/AN/A-
Total CashN/A420M-
Total DebtN/A1.38B-
FUNDAMENTALS RATINGS
AAVXF vs SRPT: Fundamental Ratings
AAVXF
SRPT
OUTLOOK RATING
1..100
4766
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
8876
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
7361
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AAVXF's Valuation (58) in the null industry is in the same range as SRPT (82) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as AAVXF (88) in the null industry. This means that SRPT’s stock grew similarly to AAVXF’s over the last 12 months.

SRPT's SMR Rating (98) in the Biotechnology industry is in the same range as AAVXF (98) in the null industry. This means that SRPT’s stock grew similarly to AAVXF’s over the last 12 months.

SRPT's Price Growth Rating (61) in the Biotechnology industry is in the same range as AAVXF (73) in the null industry. This means that SRPT’s stock grew similarly to AAVXF’s over the last 12 months.

SRPT's P/E Growth Rating (99) in the Biotechnology industry is in the same range as AAVXF (100) in the null industry. This means that SRPT’s stock grew similarly to AAVXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRPT
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 10 days ago
0%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
SRPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
CSCI - AAVXF
46%
Loosely correlated
-3.40%
SRPT - AAVXF
45%
Loosely correlated
-3.00%
ABCZF - AAVXF
31%
Poorly correlated
N/A
IMNN - AAVXF
28%
Poorly correlated
+0.17%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with BPMUF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
-3.00%
BPMUF - SRPT
52%
Loosely correlated
N/A
AAVXF - SRPT
45%
Loosely correlated
N/A
RCKT - SRPT
32%
Poorly correlated
-5.42%
SLDB - SRPT
30%
Poorly correlated
-4.50%
INZY - SRPT
30%
Poorly correlated
-3.38%
More